Similarly, liraglutide protects against gentamicin-induced AKI by activating the PGC1α/PKA/CREB and Notch1/Hes-1 pathways, thereby reducing oxidative stress, inflammation, and apoptosis (Elkhoely 2023). Here, PPARGC1A is linked to acute kidney injury.